Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 5.11 | 5.11 | 5.11 | 0 | 0 | CS |
4 | 0 | 0 | 5.11 | 5.11 | 5.11 | 0 | 0 | CS |
12 | 0 | 0 | 5.11 | 5.11 | 5.11 | 0 | 0 | CS |
26 | -3.37 | -39.7405660377 | 8.48 | 8.87 | 4.7521 | 214914 | 6.69686219 | CS |
52 | 2.29 | 81.2056737589 | 2.82 | 11.55 | 2.52 | 358621 | 5.83315913 | CS |
156 | -3.42 | -40.0937866354 | 8.53 | 11.55 | 2.21 | 150071 | 5.46249987 | CS |
260 | -11.14 | -68.5538461538 | 16.25 | 29.69 | 2.21 | 146648 | 6.93843443 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales